The hidden world of anti-phospholipid antibodies and female infertility

A literature appraisal

Cecilia B Chighizola, Guilherme R de Jesus, D Ware Branch

Research output: Contribution to journalArticle

Abstract

Even though the association of anti-phospholipid antibodies (aPL) with infertility is debated, infertile women are commonly screened for aPL. To review evidence, a systematic PubMed search was conducted to retrieve papers addressing (i) the association between aPL and infertility, (ii) the positivity rate of criteria and non-criteria aPL in women with infertility, (iii) the association between aPL and assisted reproduction technologies (ART) outcome, (iv) the efficacy of medical treatments on ART outcome, and (v) the effects of ART on thrombotic risk. A total of 46 papers were considered; several limitations emerged: (i) wide heterogeneity in study populations, (ii) non-prospective design in 90% of studies, and (iii) aPL cutoffs not conforming to international guidelines in more than 75% of studies; aPL positivity not confirmed in 89% of studies. Most studies evinced an association between infertility and anti-β2GPI antibodies and almost all non-criteria aPL. The association rate with infertility was below 50% for lupus anti-coagulant, anti-cardiolipin antibodies (aCL), and anti-phosphatidic acid antibodies. According to our estimates, overall positivity rates of criteria and non-criteria aPL tests are 6% and 3% among infertile women, 1% and 2% among controls, respectively. A significant difference in the positivity rate of patients versus controls emerged for aCL only. Five of 18 studies reported a detrimental effect of aPL on ART outcome. Only one of the six studies assessing the effects of treatment on ART outcome among aPL-positive infertile women reported a benefit. All relevant studies reported no increase in the rate of thrombosis among aPL-positive women undergoing ART.

Original languageEnglish
Pages (from-to)493-500
Number of pages8
JournalAutoimmunity Reviews
Volume15
Issue number6
DOIs
Publication statusPublished - Jun 2016

Fingerprint

Female Infertility
Anti-Idiotypic Antibodies
Phospholipids
Infertility
Reproduction
Technology
Cardiolipins
Coagulants
Phosphatidic Acids

Keywords

  • Antibodies, Antiphospholipid
  • Female
  • Humans
  • Infertility, Female
  • Prospective Studies
  • Journal Article
  • Review

Cite this

The hidden world of anti-phospholipid antibodies and female infertility : A literature appraisal. / Chighizola, Cecilia B; de Jesus, Guilherme R; Branch, D Ware.

In: Autoimmunity Reviews, Vol. 15, No. 6, 06.2016, p. 493-500.

Research output: Contribution to journalArticle

@article{0e5c5a62ba84467a9b024bf6612569cb,
title = "The hidden world of anti-phospholipid antibodies and female infertility: A literature appraisal",
abstract = "Even though the association of anti-phospholipid antibodies (aPL) with infertility is debated, infertile women are commonly screened for aPL. To review evidence, a systematic PubMed search was conducted to retrieve papers addressing (i) the association between aPL and infertility, (ii) the positivity rate of criteria and non-criteria aPL in women with infertility, (iii) the association between aPL and assisted reproduction technologies (ART) outcome, (iv) the efficacy of medical treatments on ART outcome, and (v) the effects of ART on thrombotic risk. A total of 46 papers were considered; several limitations emerged: (i) wide heterogeneity in study populations, (ii) non-prospective design in 90{\%} of studies, and (iii) aPL cutoffs not conforming to international guidelines in more than 75{\%} of studies; aPL positivity not confirmed in 89{\%} of studies. Most studies evinced an association between infertility and anti-β2GPI antibodies and almost all non-criteria aPL. The association rate with infertility was below 50{\%} for lupus anti-coagulant, anti-cardiolipin antibodies (aCL), and anti-phosphatidic acid antibodies. According to our estimates, overall positivity rates of criteria and non-criteria aPL tests are 6{\%} and 3{\%} among infertile women, 1{\%} and 2{\%} among controls, respectively. A significant difference in the positivity rate of patients versus controls emerged for aCL only. Five of 18 studies reported a detrimental effect of aPL on ART outcome. Only one of the six studies assessing the effects of treatment on ART outcome among aPL-positive infertile women reported a benefit. All relevant studies reported no increase in the rate of thrombosis among aPL-positive women undergoing ART.",
keywords = "Antibodies, Antiphospholipid, Female, Humans, Infertility, Female, Prospective Studies, Journal Article, Review",
author = "Chighizola, {Cecilia B} and {de Jesus}, {Guilherme R} and Branch, {D Ware}",
note = "Copyright {\circledC} 2016. Published by Elsevier B.V.",
year = "2016",
month = "6",
doi = "10.1016/j.autrev.2016.01.018",
language = "English",
volume = "15",
pages = "493--500",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - The hidden world of anti-phospholipid antibodies and female infertility

T2 - A literature appraisal

AU - Chighizola, Cecilia B

AU - de Jesus, Guilherme R

AU - Branch, D Ware

N1 - Copyright © 2016. Published by Elsevier B.V.

PY - 2016/6

Y1 - 2016/6

N2 - Even though the association of anti-phospholipid antibodies (aPL) with infertility is debated, infertile women are commonly screened for aPL. To review evidence, a systematic PubMed search was conducted to retrieve papers addressing (i) the association between aPL and infertility, (ii) the positivity rate of criteria and non-criteria aPL in women with infertility, (iii) the association between aPL and assisted reproduction technologies (ART) outcome, (iv) the efficacy of medical treatments on ART outcome, and (v) the effects of ART on thrombotic risk. A total of 46 papers were considered; several limitations emerged: (i) wide heterogeneity in study populations, (ii) non-prospective design in 90% of studies, and (iii) aPL cutoffs not conforming to international guidelines in more than 75% of studies; aPL positivity not confirmed in 89% of studies. Most studies evinced an association between infertility and anti-β2GPI antibodies and almost all non-criteria aPL. The association rate with infertility was below 50% for lupus anti-coagulant, anti-cardiolipin antibodies (aCL), and anti-phosphatidic acid antibodies. According to our estimates, overall positivity rates of criteria and non-criteria aPL tests are 6% and 3% among infertile women, 1% and 2% among controls, respectively. A significant difference in the positivity rate of patients versus controls emerged for aCL only. Five of 18 studies reported a detrimental effect of aPL on ART outcome. Only one of the six studies assessing the effects of treatment on ART outcome among aPL-positive infertile women reported a benefit. All relevant studies reported no increase in the rate of thrombosis among aPL-positive women undergoing ART.

AB - Even though the association of anti-phospholipid antibodies (aPL) with infertility is debated, infertile women are commonly screened for aPL. To review evidence, a systematic PubMed search was conducted to retrieve papers addressing (i) the association between aPL and infertility, (ii) the positivity rate of criteria and non-criteria aPL in women with infertility, (iii) the association between aPL and assisted reproduction technologies (ART) outcome, (iv) the efficacy of medical treatments on ART outcome, and (v) the effects of ART on thrombotic risk. A total of 46 papers were considered; several limitations emerged: (i) wide heterogeneity in study populations, (ii) non-prospective design in 90% of studies, and (iii) aPL cutoffs not conforming to international guidelines in more than 75% of studies; aPL positivity not confirmed in 89% of studies. Most studies evinced an association between infertility and anti-β2GPI antibodies and almost all non-criteria aPL. The association rate with infertility was below 50% for lupus anti-coagulant, anti-cardiolipin antibodies (aCL), and anti-phosphatidic acid antibodies. According to our estimates, overall positivity rates of criteria and non-criteria aPL tests are 6% and 3% among infertile women, 1% and 2% among controls, respectively. A significant difference in the positivity rate of patients versus controls emerged for aCL only. Five of 18 studies reported a detrimental effect of aPL on ART outcome. Only one of the six studies assessing the effects of treatment on ART outcome among aPL-positive infertile women reported a benefit. All relevant studies reported no increase in the rate of thrombosis among aPL-positive women undergoing ART.

KW - Antibodies, Antiphospholipid

KW - Female

KW - Humans

KW - Infertility, Female

KW - Prospective Studies

KW - Journal Article

KW - Review

U2 - 10.1016/j.autrev.2016.01.018

DO - 10.1016/j.autrev.2016.01.018

M3 - Article

VL - 15

SP - 493

EP - 500

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 6

ER -